ATE4383T1 - Antisekretorisch wirksame heterozyklische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Antisekretorisch wirksame heterozyklische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE4383T1
ATE4383T1 AT79302212T AT79302212T ATE4383T1 AT E4383 T1 ATE4383 T1 AT E4383T1 AT 79302212 T AT79302212 T AT 79302212T AT 79302212 T AT79302212 T AT 79302212T AT E4383 T1 ATE4383 T1 AT E4383T1
Authority
AT
Austria
Prior art keywords
antisecretory
heterocyclic
derivatives
guaranide
preparation
Prior art date
Application number
AT79302212T
Other languages
English (en)
Inventor
Tobias Oregon Yellin
Derrick Fleet Jones
Original Assignee
Imperial Chemical Industries Plc
Ici Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Plc, Ici Americas Inc filed Critical Imperial Chemical Industries Plc
Application granted granted Critical
Publication of ATE4383T1 publication Critical patent/ATE4383T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT79302212T 1978-10-16 1979-10-15 Antisekretorisch wirksame heterozyklische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. ATE4383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7840706 1978-10-16
EP79302212A EP0010894B1 (de) 1978-10-16 1979-10-15 Antisekretorisch wirksame heterozyklische Guanidinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE4383T1 true ATE4383T1 (de) 1983-08-15

Family

ID=10500371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79302212T ATE4383T1 (de) 1978-10-16 1979-10-15 Antisekretorisch wirksame heterozyklische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (6)

Country Link
US (1) US4374836A (de)
EP (1) EP0010894B1 (de)
JP (1) JPS5553288A (de)
AT (1) ATE4383T1 (de)
CA (1) CA1218066A (de)
DE (1) DE2966030D1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578459A (en) * 1973-05-03 1986-03-25 Smithkline & French Laboratories Limited Heterocyclic alkylaminoheterocycles
US4467087A (en) * 1973-05-03 1984-08-21 Smith Kline & French Laboratories Limited 1,2,4-Triazines
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
IL61234A (en) * 1979-10-24 1984-03-30 Smith Kline French Lab Guanidino thiazolyl alkylamino(alkylthioalkylamino)nitrotetrahydropyridines,process for preparing them and pharmaceutical compositions containing them
GR71929B (de) * 1979-11-13 1983-08-19 Ici Ltd
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
EP0065823A1 (de) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterozyklische Guanidinderivate als Histamin-H-2-Antagonisten
US5171860A (en) * 1981-06-15 1992-12-15 Merck & Co., Inc. Diamino isothiazole-1-oxides and 1,1 dioxides as gastric secretion inhibitors
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
EP0102026A3 (de) * 1982-08-20 1984-05-16 Hoechst Uk Limited Thiazolderivate
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4104381A (en) * 1973-05-03 1978-08-01 Smith Kline & French Laboratories Limited Pharmacologically active compounds
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors
US4218452A (en) * 1975-10-02 1980-08-19 Smith Kline & French Laboratories Limited Substituted 4-pyrimidone compounds, compositions and methods of use
IN146736B (de) 1975-10-02 1979-08-25 Smith Kline French Lab
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
MW5076A1 (en) 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) * 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
GB2001624B (en) * 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
DE2961923D1 (en) * 1978-01-18 1982-03-11 Ici Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0010894A1 (de) 1980-05-14
EP0010894B1 (de) 1983-08-03
CA1218066A (en) 1987-02-17
DE2966030D1 (en) 1983-09-08
JPS5553288A (en) 1980-04-18
US4374836A (en) 1983-02-22

Similar Documents

Publication Publication Date Title
ATE4383T1 (de) Antisekretorisch wirksame heterozyklische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK114783A (da) Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
ATE103592T1 (de) Carbamoylpyrrolidonderivate, ihre verwendung und herstellung.
ATE15663T1 (de) Cyano-2-benzimidazol-derivate, verfahren zu deren herstellung und deren anwendung als fungizide und akarizide.
ATE224T1 (de) 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
EP0091749A3 (de) Ethanolamin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ES8300745A1 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
NO873873D0 (no) Kinoxalinforbindelser samt fremgangsmaate for fremstilling derav.
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
PT76614B (de) Thiomethylpyridin-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES519153A0 (es) Procedimiento de preparacion de nuevos derivados de la benzodioxina y de sus sales de adicion acida.
ES2106439T3 (es) 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
KR910007928A (ko) 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물
ATE5724T1 (de) Guanidinverbindungen, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
ES470977A1 (es) Un procedimiento para la preparacion del compuesto 2-(gamma-(1-piperidinil)propil)-1,2-benzisotiazol-3-ona
DK500083A (da) Fremgangsmaade til fremstilling af 5-(2-alkoxyphenyl)hydantoin-forbindelser eller farmaceutisk acceptable salte deraf
DE2967648D1 (en) Utilisation of 2-(n-(2,6-dichloro-phenyl)-n-allyl-amino)-imidazoline-(2) for the production of bradycardiac drugs
DK193580A (da) Fremgangsmaade til fremstilling af 5-(2-( (2,3-dihydro-1,4-benzodioxan-2-yl-methyl)amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-derivater
OA08436A (fr) Dérivé de l'imino-3 pyridazine, procédé d'obtention et compositions pharmaceutiques en contenant.
JPS57154183A (en) Omega-piperazinylalkanoylalkylene dioxybenzenes and their acid addition salts
IE38776B1 (en) Heterocyclic-substituted 1,3,4-thiadiazole derivatives, process for their preparation and their use as herbicides
DK354681A (da) Fremgangsmaade til fremstilling af amidiner
JPS57206683A (en) Pyrimidone salt, manufacture and medicinal composition containing same
DK46884A (da) 5-aminomethyl-imidazol-1-yl-1,3-dialkyl-1h-pyrazol-4-yl-aroyl-methanoner, fremgangsmaade til deres fremstilling samt deres anvendelse
JPS6485978A (en) Novel thienodiazepine derivative

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee